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Abstract
Background: Coronary artery disease (CAD) is a major public health problem which in turn imposes a signiﬁ  cant burden 
on health care systems because of high morbidity and mortality. Although the multifactorial etiology of CAD increases with 
age, but in recent years, the incidence is increasing among younger age groups.
Objectives: In this study we aimed to evaluate the effect of age on risk proﬁ  le, inﬂ  ammatory response and the angiographic 
ﬁ  ndings in patients with ACS.
Patients and Methods: The study comprised 253 ACS patients. Seventy six (30%) with UA, 56 (22%) with NSTEMI and 
121(48%) with STEMI diagnosis. The value of Hs-CRP, lipid proﬁ  le, cardiac enzymes, risk factors, EF% and angiographic 
score were analyzed and compared in different age groups.
Results: Group 1 (n = 68) with age  45 years, group II (n = 110) with age  45– 65 years and group III (n = 75)  65 years. 
Group I had more prevalence of male sex, smoking, family history, hypertriglyceridemia and low levels of HDL (P   0.01), 
higher incidence of STEMI (P   0.01) and lower prevalence of UA (P   0.01). Diabetes mellitus, hypertension, and female 
gender were more common in older groups. Hs-CRP was signiﬁ  cantly lower in the young age (group I). Group I showed a 
preponderance of single-vessel disease, lower coronary atherosclerotic score and prevalent left anterior descending artery 
(LAD) involvement compared with older age groups. Hs-CRP was positively correlated to severity of CAD only in older groups. 
Stepwise multiple regression analysis showed that age, male gender, cardiac enzymes and EF% were common predictors of 
multivessel disease. Smoking was independent predictor in young patients  45 years while diabetes and Hs-CRP was the key 
predictor in older patient groups.
Conclusion: Young patients with ACS had different clinical, angiographic and biochemical proﬁ  le. Hs-CRP peak concen-
tration did not correlate with angiographic ﬁ  ndings in young patients that could be attributed to different risk proﬁ  le and 
discrete underlying mechanism.
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Introduction
Acute coronary syndromes (ACS) are a major health problem and account for a large proportion of the 
total number of hospitalizations all over the world.
1 There is a general agreement on a multifactorial etiol-
ogy of coronary artery disease (CAD) and that the incidence of disease increases with age.
2 Nevertheless, 
it has been recognized in young age groups more frequently in recent years.
3–4 Worldwide, about 4% of 
patients with myocardial infarction (MI) are younger than 40 years of age.
5 These patients frequently have 
characteristics that are different from those seen in older patients. While conventional risk factors clearly 
play a major role in the predisposition to MI, a signiﬁ  cant number of young patients with ACS do not have 
any of the conventional risk factors, except for a family history of CAD.
6 Furthermore, some previous 
studies have shown a correlation between C-reactive protein (CRP) and the presence of atherosclerosis,
7 
whereas others have not found a correlation.
8 CRP might lose much if not all of its predictive value in 
both secondary and primary risk settings after adjustment for quantitative angiographic measures of CAD. 
On the other hand, CRP might add independently to measures of CAD extent and severity. While there 16
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are some studies from developed countries on the 
coronary angiographic profile and risk factor 
analysis of CAD patients at all ages,
9,10 there are not 
enough published data addressing this problem in 
acute setting of CAD.
Aim of the Work
To investigate the effect of age by itself on coronary 
risk factors, inﬂ  ammatory response and angio-
graphic ﬁ  ndings in patients with ACS.
Patients and Methods
Patients admitted to the coronary care unit (CCU) 
due to unstable angina pectoris or non-ST elevation 
acute myocardial infarction (NSTEMI) or ST 
elevation acute myocardial infarction (STEMI) 
from December 2006 to January 2008 were 
considered candidates for the study.
Inclusion criteria
Inclusion criteria were deﬁ  ned as onset of chest 
discomfort in the prior 48 hours in patients with 
positive troponin (troponin I   1.0 ng/ml or 
troponin T   0.1 ng/ml) and/or electrocardio-
graphic changes consisting of transient ST-segment 
depression ( 0.05mV) or T wave inversion 
( 0.1 mV). Positive troponin patients had their 
index event deﬁ  ned as acute myocardial infarction 
and the remaining subjects were labeled as unsta-
ble angina.
11 Acute STEMI was deﬁ  ned as chest 
pain lasting for  30 min, characteristic ST-segment 
elevation of  0.1 mV in two or more contiguous 
leads on ECG, and a creatine kinase (CK)& 
CK-MB values more than twice that of the highest 
reference laboratory value.
12
Exclusion criteria
Patients with previous left bundle-branch block, 
pacemaker rhythm, acute inﬂ  ammatory illness 
(within the last month), history of malignancy or 
secondary conditions that could precipitate angina 
(anemia, arrhythmias, fever) were not included in 
this study. Patients with cardiac valve disease, 
acute or chronic liver disease, and infectious dis-
eases were also excluded from the study. None of 
the patients included in the study had ongoing 
systemic or cardiac inﬂ  ammatory processes. All 
patients gave written informed consent before 
study entry and the study was approved by the local 
research ethics committee.
Patient selection
We studied 253 consecutive patients [age ranged 
from (32–85 years), 76.6% men] admitted to CCU 
unit for the assessment of angina chest pain. 
Seventy six (30%) patients had UA; ﬁ  fty six 
(∼22%) ACS patients had NSTEMI and 121 
(∼48%) had STEMI. The clinical management of 
ACS and the decision to proceed to angiography 
was left to the discretion of the managing 
cardiologist who was unaware of results regarding 
inﬂ  ammatory markers. All enrolled ACS patients 
underwent coronary angiography during hospi-
tal admission or within three weeks after 
discharge.
A-Clinical characterization
Patient’s baseline clinical characteristics were 
evaluated. Clinical proﬁ  les included age, sex, 
smoking history, hypertension, diabetes mellitus 
(DM), previous history of CAD and family his-
tory of CAD. Smoking was classiﬁ  ed as smoker 
and non-smoker. A smoker was defined as a 
patient who had smoked cigarettes regularly at 
least 1 cigarette/day within 2 years before study 
inclusion. A non-smoker was deﬁ  ned as a patient 
without smoking a cigarette in his or her life or 
quit smoking at least two years before inclu-
sion in the study. Patients were diagnosed as 
hypertensive if told by a physician that they had 
hypertension or if they were using antihyperten-
sive medication or if either systolic blood pressure 
 140 mm Hg or diastolic blood pressure 
 90 mm Hg was detected at least twice during 
admission. DM was diagnosed as a fasting blood 
glucose  126 mg/dl at least two times in admis-
sion or if they were treated with hypoglycemic 
agents or insulin.
13 Family history of CAD was 
positive if at least one of the parents, siblings or 
children had manifestations of cardiovascular 
disease before the age of 55 years in males and 
65 years in females. Body mass index (BMI) was 
calculated using the following formula: weight 
(kg)/height
2 (m
2).
13 Dyslipidemia is diagnosed 
if plasma lipid analysis shows one or more of 
the following: hypercholesterolemia [total cho-
lesterol (TC)  200 mg/dl and/or low-density 
lipoprotein (LDL-C)  130 mg/dl]; hypertriglyc-
eridemia [triglycerides (TG)  150 mg/dl] and 
low levels of   high-density lipoprotein (HDL-C) 
[HDL-C   40 mg/dl in males and HDL-C   50 mg/dl 
in female].
1417
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B-Echocardiographic examination
After patient stabilization and within days of the 
onset of symptoms, the patients were subjected to 
detailed echocardiographic examination for 
assessment of LV function and wall motion 
abnormalities. Conventional M-mode, two-
dimensional, pulsed Doppler and color flow 
Doppler echocardiography were performed using 
the commercially available ACUSON 128 XP 10 
C. From apical and parasternal views visual assess-
ment of regional wall motion was performed. 
Septal and posterior wall thickness during diastole 
was measured. End systolic diameter and volume 
(ESD and ESV), end diastolic diameter and volume 
(EDD and EDV), fractional shortening and ejection 
fraction by Simpson’s formula were measured.
C-Laboratory assays
In addition to routine laboratory work-up including, 
blood urea and serum creatinine, fasting and 2 hour 
post-prandial blood sugar, TC, TG, LDL-C and 
HDL-C patients were subjected to laboratory 
analysis of cardiac enzymes, CK-MB, total CPK, 
LDH. A blood sample to measure high sensitivity 
C reactive protein (Hs-CRP), as an inﬂ  ammatory 
marker, was drawn immediately at hospital arrival, 
targeting the least possible time delay from symp-
toms onset before any therapeutic interference.
High sensitivity C-reactive protein
Fasting blood samples were obtained from ACS 
patients at the time of admission to CCU. Hs-CRP 
was measured using a commercially available 
immune-enzymatic method (Dade-Behring, 
Newark, Delaware, U.S.A.) with a precision limit 
of 0.3 mg/L and variation coefﬁ  cient of 7.6%.
15 
Analytical precision of the Hs-CRP-Latex assay 
was 7.6% at a level of 1.02 mg/L, 3.3% at 1.79 mg/L 
and 1.3% at a level of 4.36 mg/L. Samples outside 
the analytical range of the high sensitivity CRP-
Latex assay were analyzed by the CRP-Latex assay 
in the normal application.
15
Angiographic analyses
Diagnostic coronary angiography (CA) was carried 
out in all patients using Judkins technique. Quan-
titative analysis of coronary arteries was performed 
with the computer-assisted Coronary Angiography 
Analysis System. End-diastolic frames from each 
arteriogram were selected for analysis.
16 The 
percentage diameter stenosis (DS) was assessed in 
different projections and the highest value of each 
lesion, was chosen. Images of the coronary tree 
were obtained with the digital SIEMENS HICOR 
1000 set system. Two experienced cardiologists 
who had no knowledge of the patients’ clinical 
characteristics and biochemical results reviewed 
all angiographic images to assess the extent of CAD 
and morphology of all coronary artery stenoses.
Coronary angiograms were scored according 
to two scores
1. Vessel score: This was the number of vessels 
with a signiﬁ  cant stenosis (50% or greater reduc-
tion in lumen diameter). Degree of stenosis was 
deﬁ  ned as the greatest percentage reduction of 
luminal diameter in any view compared with the 
nearest normal segment and was determined visu-
ally. Scores ranged from 0 to 3, depending on the 
vessels involved. Left main artery stenosis was 
scored as single vessel disease.
17
2. Severity score: Using the scoring system 
described by Reardon et al.
18 for analysis, the 
coronary circulation was divided into eight 
proximal segments. Disease in the distal segments 
was not considered because of difﬁ  culty in quan-
titating the severity of lesions in these areas. The 
eight proximal segments scored included the left 
main coronary artery, the left anterior descending 
artery (LAD) up to the junction of the middle and 
distal third of the vessel, the proximal third of the 
major septal branch of the LAD, the proximal 
third of the major diagonal branch of the LAD, 
the left circumﬂ  ex coronary artery (LCX) up to 
the junction of the middle and distal thirds of the 
vessel, the proximal third of the major obtuse 
marginal branch of the LCX, the right coronary 
artery (RCA) up to and including the origin of 
the posterior descending coronary artery (PDA), 
and the proximal third of the PDA. In cases in 
which the PDA was supplied by the LCX vessel 
(LCX dominance), lesions in the LCX up to the 
origin of the PDA were included, as were lesions 
of the RCA up to the origin of the middle and 
distal thirds of the vessel. The PDA was scored 
identically for RCA and LCX dominant circula-
tions. The percentage by which each lesion in the 
proximal coronary circulation narrowed the artery 
was assessed according to the maximal narrowing 
of the diameter of the artery in all projections. 
The severity of the proximal coronary disease 
was assessed by assigning points to each lesion 
as follows: less than 50% stenosis of the luminal 
diameter, 1 point; 50% to 74% stenosis, 2 points; 18
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75% to 99% stenosis, 3 points; total obstruction, 
4 points. The points for each lesion in the proxi-
mal coronary circulation were summed and a 
score for severity of coronary atherosclerosis was 
obtained. In previous study, the coefﬁ  cient of 
variation between two angiograms analyzed sev-
eral months apart without knowledge of the 
previous score was 4.9%.
18
Statistical analysis
The collected data were tabulated and analyzed by 
SPSS statistical package version II on IBM 
compatible computer. Quantitative data were 
expressed as mean value ± SD and analyzed with 
student t-test for comparison of normally distributed 
values, and Mann Whitney U test for abnormally 
distributed ones. Chi-square test was used for 
analysis of qualitative data. Spearman correlation 
coefﬁ  cient test was used to detect the association 
between 2 quantitative variables. A value of 
P   0.05 (test of signiﬁ  cance at 5% level) was 
considered statistically significant. Pearson 
correlation coefﬁ  cient was used to evaluate the 
relation of different clinical, echocardiographic and 
angiographic variables to Hs-CRP and the relation 
of these variables to coronary artery scoring. 
Multivariate analysis was used to assess the 
predictors of multivessel disease in ACS patients.
Results
Patient population and demographics
The present study included 253 patients (194 males, 
59 females) with ACS with age ranged from 
(32–85 years) recruited from CCU. To examine the 
relationship of age to risk proﬁ  le, Hs-CRP and the 
severity of CAD in patients with ACS, patients was 
classiﬁ  ed according to their age into 3 groups:
•  Group I: included 68 patients with age  45 
years.
•  Group II: included 110 patients with age 
 45–  65 years.
•  Group III: included 75 patients with age  65 
years old.
Baseline demographics are presented by age 
category in table (1). Young ACS patients  45 years 
old represented 26.9% of total population. While 
older group  65 years represented 29.6% of total 
population. The residual 43.5% of ACS were in 
middle age between 45–65 years age.
Male sex, smoking, positive family history, 
hypertriglyceridemia and low levels of HDL were 
more prevalent in group I while DM, hypertension 
and female gender were more common in group II 
and III. (Table 1, Figs. 1 and  2). ACS patients  65 years 
(group III) had higher incidence of diabetes com-
pared with group II (P   0.001) and lower HDL 
(P   0.01) that could be related to physical inactiv-
ity. There was statistically signiﬁ  cant difference in 
obesity prevalence between the groups. Group II 
and III had higher prevalence of obesity compared 
to young group (P   0.01).
Clinical presentation and medications 
of study patients with ACS
From total of 253 subjects enrolled who had 
angiographic and baseline demographic information 
and a baseline Hs-CRP level, patients presenting 
with symptoms consistent with unstable angina 
(UA) 76 comprised (∼30%) of the study cohort; 
NSTEMI (n = 56) presentation made up ∼22%; 
while STEMI (n = 121) comprised the remaining 
48%. As regards to SBP and DBP, group II and III 
had higher levels in comparison to group I 
(144 ±  26 and 150 ± 35 vs. 122 ± 11 mmHg for 
SBP, 89 ± 23 and 94 ± 19 vs. 74 ± 10 mmHg for 
DBP, P   0.01 for each respectively) where hyper-
tension was more prevalent in such groups 
(group II and III).
Comparing the three age groups in their clinical 
presentation, young ACS patients (group I) had 
higher incidence of STEMI compared with group II 
and III [39(57%) vs. 47(43%) and 35(47%) P   0.01] 
and lower prevalence of UA [19(28%) vs. 40(36%) 
and 17(23%) P   0.01] respectively. Additionally, 
older group had higher prevalence of NSTEMI in 
comparison to group I [23(31%) vs. 10(15%) P   0.001] 
and group II [23(31%) vs. 23(21%) P   0.01] 
respectively (Fig. 3).
Rates of medications during hospitalization 
were 87.7% for aspirin, 86.9% for nitrate, 73.5% 
for angiotensin converting enzyme (ACE) inhibi-
tors or ARBs, 71.1% for beta-blockers and 82.2% 
for statins, 89.3% for clopidogrel. No signiﬁ  cant 
difference between different age groups in 
prescribed medications during hospitalization. 
Thrombolytic therapy was started more frequent 
in younger age group [32(47%) vs. 40(36%) and 
29(39%) P   0.01].
Among the entire group, angioplasty was 
recommended for 21 patients (8.3%), 24 patients 19
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(9.4%) were sent for surgery and medical therapy 
was prescribed to the 208 patients (∼82%).
Laboratory ﬁ  ndings in studied groups: 
(Table 2)
Plasma glucose levels of group III patients in our 
study population were commonly not under 
control. Comparison of the fasting glucose, 
TC, HDL, LDL and TG levels of the patients 
are shown in Table 2. TC were signiﬁ  cantly 
increased in older age groups ( 45 years) 
compared with group I (P   0.001), LDL-C and 
HDL-C were signiﬁ  cantly higher, P   0.001, 
P   0.01 in group II and III for LDL-C and 
P   0.01 for HDL-C while TG was signiﬁ  cantly 
lower (P   0.001, P   0.01) respectively com-
pared with group I.
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Figure 1. Prevalence of risk factors in studied patients with ACS.
Table 1. Risk proﬁ  le of study patients with ACS.
Group I (n = 68) Group II (n = 110) Group III (n = 75)
Age in years (mean ±SD) 33.2 ± 2.9 50.2 ± 4.8* 69.3 ± 3.5**
Male 64 (94.1%) 70 (72.7%)* 60 (80%)*
Female 4 (5.9%) 40 (27.3%)* 15 (20%)*
BMI   25 kg/m
2 (%) 32 (47%) 74 (67%)* 50 (67%)*
Smoking (%) 54 (79%) 40 (36%)* 32 (42%)*
Hypertension (%) 15 (23%) 55 (59%)* 49 (65%)*
Diabetes mellitus (%) 5 (7%) 33 (30%)* 40 (53%)**^
Positive FH (%) 30 (44%) 22 (20%)* 10 (13%)*
Hypercholesterolemia (%) 26 (38%) 50 (45%)* 35 (47%)*
Hypertriglyceredemia (%) 36 (53%) 40 (36%)* 30 (40%)*
Low HDL (%) 52 (76%) 51 (46%)* 45 (60%)*^
Abbreviations: BMI, body mass index; UA, unstable angina; NSTEMI, non ST elevation myocardial infarction; STEMI, ST elevation myocardial 
infarction; ACEI, angiotensin converting enzyme inhibitor.
*gp II and III vs. I, P   0.01. **gp II and III vs. I, P   0.001. ^grp III vs. II, P   0.01.20
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Cardiac enzymes (CPK, CK-MB and LDH) in 
patients with STEMI were signiﬁ  cantly elevated 
in group II and III compared with younger group 
despite higher prevalence of STEMI in this group. 
This could be ascribed to greater number of the 
other two groups and larger number of diseased 
coronaries and infarct areas.
Besides, Hs-CRP was signiﬁ  cantly lower in 
younger age group (group I) in comparison to 
group II and group III (P   0.01, P   0.001, respec-
tively) and the higher values were observed in older 
age group (group III) (P   0.01 versus group II). 
Serum creatinine and blood urea were signiﬁ  cantly 
higher in older age group (P   0.01) (Fig. 4).
Echocardiographic ﬁ  ndings 
in studied populations
From all echocardiographic measurements 
merely EF% was significantly lower in group 
II (52.8 ± 13.1%) and III (49 ± 5.8%) compared 
with younger group I (58.3 ± 6.1%), (P   0.01). 
Also, wall motion abnormality was significantly 
prevalent in older groups [group II: 74(67%) 
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Figure 2. Comparison of dyslipidemia between different age groups (P   0.01).
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Figure 3. Comparison of clinical presentation with ACS in different age groups (P   0.01).21
Age-related alteration of risk proﬁ  le, inﬂ  ammatory response, and angiographic ﬁ  ndings in patients with acute coronary syndrome
Clinical Medicine: Cardiology 2009:3 
and group III: 55 (73%) vs. group I: 20 (29%), 
P   0.001] respectively.
Analysis of angiographic data 
in ACS patients
Three patients (4.0%) of group I had normal 
coronary arteries (vessel score 0) which is not 
seen in any of the older patient groups. Besides, 
multivessel disease was detected more frequently 
in older patients (group II, III vs. group I) (62% and 
73% vs. 29%, p   0.001). Patients in group I 
showed a preponderance of single-vessel disease 
compared with patients in group II and III 
(p   0.001) and signiﬁ  cantly less common in 
group III compared with group II (P   0.01) 
(Fig. 5). The prevalence of critical LAD involve-
ment was different between the studied groups. 
Group I and III had prevalent involvement of 
LAD compared with group II (P   0.01). 
However RCA and LCX signiﬁ  cant stenoses 
were more common in group II compared with 
Table 2. Comparison of laboratory ﬁ  ndings between studied groups.
Group I (n = 68) Group II (n = 110) Group III (n = 75)
Fasting glucose, mg/dl 92 ± 15 127 ± 24* 146 ± 27**^
Total cholesterol, mg/dl 192 ± 25 233 ± 43** 230 ± 39**
LDL-cholesterol, mg/dl 120 ± 12 147 ± 28** 140 ± 28*
HDL-cholesterol, mg/dl 34 ± 13 43 ± 15* 42 ± 18*
Triglyceride, mg/dl 158 ± 27 140 ± 14** 145 ± 17*
CPK 534.9 ± 423.3 743 ± 345.5* 814.6 ± 431.7*
CK-Mb 28.3 ± 23.4 34.8 ± 26.7* 32.9 ± 37.3*
LDH 645 ± 158.4 823.7 ± 650* 798.9 ± 643.3*
Hs-CRP (mg/l) 6.1 ± 1.2 8.4 ± 2.9* 11.5 ± 3.2**^
Serum creatinine (μg/l) 0.76 ± 0.21 0.82 ± 0.34 0.96 ± 0.67*
Blood Urea (mmol/l) 29 ± 3.4 31 ± 4.9 34 ± 7.9*
Abbreviations: CPK, creatinine phosphokinase; LDH, lactic dehydrogenase; Hs-CRP, high sensitive C-reactive protein.
*gp II and III vs. I, P   0.01. **gp II and III vs. I, P   0.001. ^grp III vs. II, P   0.01.
6.10
11.50
8.40
0
2
4
6
8
10
12
14
Group I                           Group II                          Group III
(
m
g
/
l
)
Hs-CRP
P < 0.01
P < 0.001
Figure 4. Comparison of Hs-CRP between different age groups.22
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group I (P   0.01) and group III (P   0.01). 
Coronary artery score was signiﬁ  cantly lower in 
younger group (4.77 ± 2.50) in comparison to 
group II and III (6.49 ± 6.17, 9.43 ± 6.61) 
P   0.01, P   0.001 respectively. (Fig. 6) There 
was no statistically significant difference 
between groups in the frequency of left main 
coronary artery stenosis. Coronary angiographic 
ﬁ  ndings between the two groups are shown in 
Table 3.
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Figure 5. Comparison of vessel score in the different age groups.
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Figure 6. Severity scoring of CAD in different age groups.23
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Correlations of CRP with risk factors 
of CAD: (Table 4)
Despite no relation was detected between prevalence 
of risk factors and plasma level of Hs-CRP, increas-
ing age of patients was associated with higher 
values of Hs-CRP during acute coronary settings. 
Also Hs-CRP was positively correlated with the 
cardiac enzymes (CPK: r = 0.337, P   0.001) and 
(LDH, r = 0.319, P   0.007), triglycerides level 
(r = 137, P   0.03) and negatively with EF% 
(r = −0.265, P   0.002) in the entire cohort of 
ACS patients. As regard the severity of coronary 
diseases, Hs-CRP was positively correlated with 
coronary severity score (r = 0.249, P   0.002) and 
the number of vessels diseased (r = 0.314, 
P   0.001) just in whole ACS patients.
Relationship of Hs-CRP to severity 
of CAD in different age groups
When taken individually, Hs-CRP was positively 
correlated to severity of coronary diseases in the 
middle age group (group II, P   0.03) and the 
old age group (group III, P   0.01) but not in 
the young group  45 years. However, age, which 
was also correlated with Hs-CRP, showed 
positive correlation to severity of coronary 
disease in all age groups (P   0.01, 0.02, 0.001 
respectively).
Male gender was associated positively with more 
severe CAD. While smoking was positively corre-
lated to the extent of CAD in young patients with 
ACS (P   0.001). Diabetes mellitus was related 
signiﬁ  cantly to CAD severity in patients  45 years 
(P   0.001, 0.009 respectively). The univariate 
analysis revealed that cardiac enzymes also related 
to the extent of CAD while left ventricular EF% was 
negatively correlated with it P   0.01 (group I), 
P   0.02 (group II), P   0.01 (group III), (Table 4).
After stepwise multiple regression analysis, 
independent predictors of the multivessels disease 
were different according to age group. While age, 
male sex, cardiac enzymes and EF% were common 
predictors of multivessel disease in all age groups, 
smoking was independent predictor in young 
patients  45 years old (OR 121, 95% CI: 0.023–0.226, 
P   0.001) while diabetes and Hs-CRP were the 
key predictors in older patient groups (group II, III) 
(OR 0.167, 95% CI: 0.12–0.33, P   0.0001, 
OR 2.01, 95% CI: 1.14–3.23, P   0.007) respec-
tively. (Tables 5, 6).
Discussion
Premature CAD has been deﬁ  ned as having an age 
of onset ranging from 30 to 56 years in various stud-
ies. We selected an age cut-off point of 45 years to 
deﬁ  ne a premature coronary artery disease based on 
previous epidemiologic studies.
19 In this study, when 
comparing traditional risk factors for CAD, cigarette 
smoking was the most prevalent risk factor, with 
79% of ACS subjects being smokers. This was fol-
lowed by dyslipidemia; 76% had low HDL, 53% of 
patients had hypertriglyceridemia. This is followed 
Table 3. Angiographic data in the different study groups.
Group I (n = 68) Group II (n = 110) Group III (n = 75)
Vessel score
0 3 (4%) 0 0
1 45 (66%) 42 (38%)** 20 (27%)**^
2 14 (21%) 39 (35%)** 25 (33%)**
3 6 (9%) 29 (27%)** 30 (40%)**^
Involvement of coronary arteries
Left main 1 (1%) 5 (5%) 3 (4%)
LAD 48 (71%) 71 (64.5%)* 69 (92%)*^
LCX 9 (13%) 61 (55%)** 27 (36%)*^
RCA 16 (24%) 55 (50%)** 18 (24%)^
Coronary Score 4.77 ± 2.50 6.49 ± 6.17* 9.43 ± 6.61**^
Abbreviations: LAD, left anterior descending; LCX, left circumﬂ  ex; RCA, right coronary artery.
*gp II and III vs. I, P   0.01. **gp II and III vs. I, P   0.001. ^grp III vs. II, P   0.01.24
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Table 4. Relationship of Hs-CRP and other clinical variables to the severity of coronary diseases in different 
study groups.
Coronary severity score Group I (n = 68) Group II (n = 110) Group III (n = 75)
Hs-CRP r 0.051
p 0.369
r 0.239
p 0.034
r 0.334
p 0.012
Age r 0.356 
p 0.011
r 0.363 
p 0.024
r 0.434 
p 0.001
Gender (male) r 0.401 
p 0.012
r 0.321
p 0.031
r 0.255 
p 0.041
BMI   25 Kg/m
2 r 0.151 
p 0.461
r 0.021 
p 0.829
r 0.074 
p 0.669
Smoking r 0.450 
p 0.001
r 0.162 
p 0.481
r 0.251 
p 0.363
Hypertension r 0.001 
p 0.532
r 0.026 
p 0.569
r 0.011 
p 0.769
Diabetes mellitus r 0.032 
p 0.469
r 0.551 
p 0.001
r 0.451 
p 0.009
Total cholesterol r 0.150 
p 0.389
r 0.247 
p 0.089
r 0.198 
p 0.095
Triglyceride r 0.201 
p 0.051
r 0.071 
p 0.429
r 0.078 
p 0.521
LDL r 0.032 
p 0.460
r 0.155 
p 0.476
r 0.064 
p 0.257
HDL r 0.211 
p 0.071
r 0.091 
p 0.466
r 0.051 
p 0.268
CPK r 0.651 
p 0.019
r 0.451 
p 0.013
r 0.551 
p 0.039
LDH r 0.591 
p 0.009
r 0.511 
p 0.002
r 0.498 
p 0.012
EF% r −0.411 
p 0.019
r −0.311 
p 0.029
r −0.453 
p 0.012
Abbreviations: Hs-CRP, high sensitive; C-reactive protein. BMI, body mass index; LDL-C, low density lipoprotein; HDL-C, high density 
lipoprotein; CPK, creatinine phosphokinase; LDH, lactic dehydrogenase; EF%, ejection fraction.
by the prevalence of positive family history (44%). 
There was a statistically signiﬁ  cant difference in low 
HDL cholesterol levels and triglycerides in young 
as compared with older ACS patients.
Our ﬁ  ndings that cigarette smoking, positive 
family history and low HDL are the most common 
risk factors in younger patients with ACS, while 
hypertension and diabetes mellitus are more com-
mon in older ones, are in agreement with earlier 
observations.
9,14,20,21 Smoking and low level of 
HDL were the main predictors for multivessel 
disease in premature ACS while diabetes and 
Hs-CRP were the most common risk predictors 
among older patients in our study.
A strong familial tendency was seen in our 
young ACS population; these observations concur 
with ﬁ  ndings in a South American study in which 
the prevalence of a positive family history was 
31% for MI cases compared with 15% in control 
subjects
22 and support the presumption of the role 
of underlying genetic mechanisms.
Several studies have identiﬁ  ed genetic predis-
position in an estimated frequency between 5 and 
14% in white Caucasian populations
23,24,25 and 
is considered by some to be a genetic risk factor 
for MI.
23,26 This association may be particularly 
evident in those with early onset ( 45 years of 
age) CAD.
27
Furthermore, in the existing study, the preva-
lence of diabetes was low in our young patients 
(7%) which are in agreement when compared with 
the ﬁ  ndings of Imazio et al.
28 in Caucasians; where 25
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Table 5. Multivariate predictors of the extent of CAD in the young patients (group I).
Odd ratio (OR) 95% Conﬁ  dence 
interval (CI)
T P value
Age 1.194 1.045–1.363 2.42 0.009
Gender (male) 1.235 1.046–2.123 3.57 0.007
Smoking 0.121 0.023–0.226 2.05 0.0001
Triglycerides 0.001 1.05–2.33 0.065  0.05
HDL-C 1.176 0.0934–2.143 2.65  0.001
CPK 0.052 0.031–0.173 2.54  0.001
LDH 0.182 0.11–0.360 3.38  0.001
EF% 0.341 0.105–2.36 2.14  0.01
Abbreviations: HDL-C, high density lipoprotein; CPK, creatinine kinase, LDH, lactic dehydrogenase, EF%, ejection fraction.
they described diabetes as being more prevalent in 
an older population. The relatively low incidence 
of hypertension (23%) in our study is similar to 
the results reported by Seedat and Mayet,
29 who 
found a prevalence of hypertension in 19% of their 
Indian-based population. These ﬁ  ndings suggest 
that neither diabetes nor hypertension are major 
risk factors for ACS in young patients.
In the present study, Hs-CRP was considerably 
elevated in older age groups compared with young 
patients with ACS. This could be explained by dif-
ferent risk profile especially the prevalence of 
diabetes. Sanchez et al.
30 ascertained that inﬂ  amma-
tion appears more evident in diabetic than in non-
diabetic patients with ACS as assessed with CRP 
concentration and other inﬂ  ammatory markers.
Besides, in the current study, we have shown 
that in ACS, Hs-CRP signiﬁ  cantly higher and cor-
relates with the extent of vascular disease in middle 
age and elderly patients. Also the independent 
contribution of Hs-CRP to risk assessment remains 
very large. However, the degree of this association 
in young patients with ACS is non considerable.
Because Hs-CRP is not correlated with angio-
graphic scores in young group, it appears that 
Hs-CRP is stimulated not only by the extent of 
atherosclerosis but, importantly, by other factors. 
It is postulated that Hs-CRP is a measure of 
inﬂ  ammed, unstable atherosclerotic plaque (both 
angiographically visible and occult), whereas 
angiography indicates only the extent of visible 
plaques. Hs-CRP also may reﬂ  ect systemic but 
nonvascular chronic inﬂ  ammatory and infectious 
processes that impact risk of acute coronary events 
by inﬂ  uencing levels of circulating proinﬂ  amma-
tory and prothrombotic factors.
Additionally, the present study indicates that 
young patients  45 years have a higher frequency 
of angiographically less extensive disease and 
single vessel disease compared with other 
groups. Similar results have been reported by 
other authors.
31–33 Histopathologic studies have 
Table 6. Multivariate predictors of the extent of CAD in the older patients with ACS (group II and III).
Odd ratio (OR) 95% Conﬁ  dence interval 
(CI)
T P value
Age 1.120 1.045–1.214 2.42  0.003
Gender (male) 0.005 1.016–1.523 0.057  0.05
Diabetes mellitus 0.167 0.124–0.326 3.05  0.0001
Hs-CRP 2.01 1.14–3.23 4.065  0.007
CPK 0.042 0.022–1.153 2.58  0.001
LDH 0.172 0.141–0.260 2.38  0.001
EF% 1.342 0.873–2.300 3.121  0.001
Abbreviations: Hs-CRP, high sensitive C-reactive protein; CPK, creatinine kinase; LDH, lactic dehydrogenase; EF%, ejection fraction.26
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demonstrated that atherosclerotic plaques in young 
patients with coronary artery disease are character-
ized by a large amount of lipid-containing foam 
cells and relative lack of a cellular scar tissue.
34 
These data suggest that soft plaques seen in young 
patients may have been present for a shorter time 
of period than plaques in older patients, which have 
a large content of ﬁ  brous tissue and are responsible 
for most episodes of major coronary thrombosis.
35 
The less extensive CAD observed in younger 
patients in our study might suggest that premature 
CAD is associated with short-lived and rapid dis-
ease progression rather than with a gradually 
evolving process. This is in agreement with the 
previous observations that, STEMI is the common 
ﬁ  rst presentation in younger patients.
32–33
In agreement with our results, Borrás Pallé 
et al. 
36 analyzed the inﬂ  ammatory state of 61 
patients with UA and NSTEMI using Hs-CRP, 
leukocytes and ﬁ  brinogen as inﬂ  ammatory markers. 
They found that, despite elevated levels of Hs-CRP 
in ACS groups these markers were not related to 
the risk of cardiovascular complications.
In contrast Correia et al.
37 studied CRP measured 
at admission of patients with non-ST-elevation 
ACS and concluded that CRP adds prognostic 
information to the TIMI-Risk Score and the 
incorporation of this variable into the TIMI-Risk 
Score calculation is a useful ingredient.
Precedent Outlook
Several trials have evaluated the predictive value 
of CRP and Hs-CRP for cardiovascular risk. 
However, much remains to be learned to explain 
CRP’s association with risk. Levels of CRP that 
deﬁ  ne increased risk vary depending on the popula-
tion studied. The degree of elevation of CRP that 
identiﬁ  es increased risk has not been clearly deter-
mined, and the clinical utility of CRP after adjust-
ment for angiographic ﬁ  ndings has been uncertain. 
C-reactive protein previously has been proposed to 
correlate with the extent of atherosclerosis.
38,39 
Studies have shown that lower proﬁ  le plaques are 
more numerous than “signiﬁ  cant stenoses” and 
therefore, are statistically more likely to lead to 
plaque rupture than the relatively few lesions of 
 70% stenosis.
40 Thus, it is possible that an ele-
vated CRP simply represents a more diffuse process 
of coronary atherosclerosis with a higher total 
plaque burden. If so, the predictive value of CRP 
would be considerably less after adjustment for 
extent of disease (total number of lesions) assessed 
by coronary angiography. To exclude this possibil-
ity, the predictive value of CRP must be adjusted 
for measures of all visible atherosclerotic plaques 
on angiography. On the other hand, if CRP levels 
primarily represent plaque properties (i.e. inﬂ  am-
mation, instability), knowledge of CRP levels would 
continue to be useful even in the presence of 
angiographic assessment of plaque burden (extent/
severity). Similarly, CRP and coronary calcium 
score (assessed by ultrafast computed tomography) 
may have independent and additive prognostic 
value, but this has not been extensively evaluated.
In the present study a negative correlation was 
found between Hs-CRP levels and ejection fraction 
while Hs-CRP levels where positively correlated 
with angiography ﬁ  ndings (number of stenotic 
vessels, lesion scoring) only in older study groups. 
Again regarding the mechanisms implicated on the 
prediction of coronary disease severity by Hs-CRP, 
it can be related to either a direct or indirect effect 
of this protein. During ACS a considerable increase 
in plasma CRP takes place as part of the acute 
phase reaction.
41
In our study, ACS younger patients (with less 
extensive CAD), Hs-CRP was not a good predictor 
of atherosclerotic severity. In these circumstances, 
the high concentrations of Hs-CPR may be not a 
marker of chronic atherosclerotic changes with 
acute exacerbation but rather a result of acute 
plaque rupture. So Hs-CRP could be used as a risk 
predictor for acute cardiovascular events. It is 
documented that CRP activates complement which 
may cause myocardial damage, predisposing to 
heart failure or arrhythmias especially following 
acute vascular stress.
42 Lastly the increase in 
plasma Hs-CRP levels in young during ACS seems 
to be linked to pre-existing inﬂ  ammation rather 
than the extension of myocardial damage.
Study Limitations
Quantiﬁ  cation of coronary angiographic ﬁ  ndings 
was limited to the visual interpretation of the 
attending cardiologist, which is representative of 
“real-world” practice. Intravascular ultrasound 
could be expected to give increased measures of 
atherosclerotic burden by identifying “intramural 
plaques,” although this would be impractical to 
apply routinely. However, whether intravascular 
ultrasound assessments would adversely impact 
predictive value of CRP is unclear.27
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Only patients with clinical presentations 
suggesting unstable angina or infarction who 
underwent angiography were included in our study. 
However, the vast majority of patients undergoing 
angiography today do so for evaluation of sus-
pected angina. Many of these patients (about 20%) 
have normal angiograms. It is often difﬁ  cult to 
determine which of these patients have true angina 
related to occult microvascular disease or endothe-
lial dysfunction and which truly have non-cardiac 
chest discomfort. Hs-CRP thus appears to be useful 
in evaluating risk in patients without visible CAD, 
although the beneﬁ  cial effects of more aggressive 
medical therapy in these patients
43,44 should be 
further evaluated.
Conclusion
Our study shows a signiﬁ  cantly different clinical, 
angiographic and biochemical proﬁ  le in young 
patients ( 45 years) with ACS compared with 
those  45 years ones. Patients with premature 
CAD commonly have different risk proﬁ  le, less 
extensive CAD than the older ones.
Hs-CRP plasma concentrations showed a 
different release pattern in young patients with 
ACS in comparison with elderly. Hs-CRP peak 
concentrations did not correlate with angiographic 
findings in young that could be attributed to 
different risk proﬁ  le.
In our study and consistent with epidemiologic 
studies; positive family history, smoking, elevated 
triglycerides levels and low HDL-cholesterol level 
were also associated with premature ACS. 
Dominance of smoking and dyslipidemia that are 
the preventable risk factors in premature CAD 
patients is an important threat for young adult. 
Healthy life styles should be encouraged beginning 
from young ages and new precautions about 
smoking must be taken.
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